NASDAQ: APVO
Aptevo Therapeutics Inc Stock Ownership - Who owns Aptevo Therapeutics?

Insider buying vs selling

Have Aptevo Therapeutics Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when APVO insiders and whales buy or sell their stock.

APVO Shareholders

What type of owners hold Aptevo Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fuad Elhibri91.91%3,021,899$4.96MInsider
Scott C. Stromatt6.58%216,183$354.54kInsider
Jane A. Gross3.33%109,583$179.72kInsider
Shawnte Mitchell2.45%80,527$132.06kInsider
Randy Joe Maddux2.28%75,000$123.00kInsider
Michael Adelman2.14%70,426$115.50kInsider
Birchview Capital LP0.30%10,000$16.40kInstitution
Tower Research Capital LLC Trc0.04%1,192$1.95kInstitution
Sbi Securities Co Ltd0.02%588$964.32Institution
Marvin L. White0.00%12$19.68Insider

1 of 3

APVO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
APVO0.33%99.67%
KZIA0.22%33.42%
CMND11.47%0.00%
SLXN5.24%94.76%
GNPX2.00%15.22%Net SellingNet Selling

Aptevo Therapeutics Stock Ownership FAQ

Who owns Aptevo Therapeutics?

Aptevo Therapeutics (NASDAQ: APVO) is owned by 0.36% institutional shareholders, 108.69% Aptevo Therapeutics insiders, and 0.00% retail investors. Fuad Elhibri is the largest individual Aptevo Therapeutics shareholder, owning 3.02M shares representing 91.91% of the company. Fuad Elhibri's Aptevo Therapeutics shares are currently valued at $4.96M.

If you're new to stock investing, here's how to buy Aptevo Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.